Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

TiMBER: tumor-informed ctDNA and recurrence in muscle-invasive bladder cancer

Observational study of the Labcorp Plasma Detect assay in patients planned for curative-intent treatment of muscle-invasive urothelial carcinoma, with concordance between recurrence and ctDNA as the primary objective.

OHSU Knight Cancer Institute